Instituto de Oncologia de Piracicaba S/S Ltda.
Piracicaba, SP, Brazil
Health in Piracicaba, State of São Paulo
Av. Independência, 940 - Higienópolis, Piracicaba - SP, 13416-225
About Instituto de Oncologia de Piracicaba S/S Ltda.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Instituto de Oncologia de Piracicaba S/S Ltda.
During the past decade, Instituto de Oncologia de Piracicaba S/S Ltda. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
2008-04-01
2015-04-01
Completed
791
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
2013-10-14
2021-03-05
Completed
431
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia de Piracicaba S/S Ltda."
#1 collaborator was "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto de Oncologia de Piracicaba S/S Ltda.
According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia de Piracicaba S/S Ltda." are
"BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials), "Breast Neoplasms" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Instituto de Oncologia de Piracicaba S/S Ltda." in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Oncologia de Piracicaba S/S Ltda.
Most popular intervention types in "Instituto de Oncologia de Piracicaba S/S Ltda." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Interferon-Alfa 9MU" (1 trials), "Physician's-Choice" (1 trials), "Temsirolimus" (1 trials) and "talazoparib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Oncologia de Piracicaba S/S Ltda.
The vast majority of trials in "Instituto de Oncologia de Piracicaba S/S Ltda." are
2 trials for "All" genders.
Clinical Trials Status at Instituto de Oncologia de Piracicaba S/S Ltda.
Currently, there are NaN active trials in "Instituto de Oncologia de Piracicaba S/S Ltda.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto de Oncologia de Piracicaba S/S Ltda.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Oncologia de Piracicaba S/S Ltda., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".